Work

AB0496 Corticosteroid Use across 52 Weeks of Belimumab Therapy in SLE Patients with High Disease Activity: Combined Analyses from the BLISS Trials

Year: 2014

Type: conference-abstract

Source: Annals of the Rheumatic Diseases

DOI: 10.1136/annrheumdis-2014-eular.4969

Authors: R. Van Vollenhoven, M. Petri, D.J. Wallace, D. Roth, C. Molta, A. Hammer, T. Tang, A. Thompson

Institutions: Karolinska Institutet, Johns Hopkins University, Cedars-Sinai Medical Center, GlaxoSmithKline (United States)

Language: English

Topic: Systemic Lupus Erythematosus Research

Subfield: Rheumatology

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: closed

OpenAlex ID: W2328416996

Cites: 1

Cited by:

Related to: 10